NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 143 filers reported holding NEKTAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,020,000 | -57.0% | 82,325 | -6.4% | 0.02% | -58.5% |
| Q1 2018 | $9,345,000 | +300.6% | 87,943 | +125.1% | 0.05% | +307.7% |
| Q4 2017 | $2,333,000 | +688.2% | 39,070 | +216.6% | 0.01% | +550.0% |
| Q3 2017 | $296,000 | +55.0% | 12,340 | +10.9% | 0.00% | 0.0% |
| Q3 2016 | $191,000 | -10.7% | 11,125 | -26.1% | 0.00% | 0.0% |
| Q2 2016 | $214,000 | -15.1% | 15,045 | -27.8% | 0.00% | -33.3% |
| Q1 2014 | $252,000 | +104.9% | 20,824 | +91.9% | 0.00% | +200.0% |
| Q4 2013 | $123,000 | -72.7% | 10,854 | -74.9% | 0.00% | -83.3% |
| Q3 2013 | $451,000 | -11.2% | 43,224 | -1.7% | 0.01% | -14.3% |
| Q2 2013 | $508,000 | – | 43,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |